장시간 최소유량 Sevoflurane 마취가 수술 후 간기능과 신기능에 미치는 영향 = The Effects of Prolonged Minimal-flow Sevoflurane Anesthesia on Postoperative Hepatic and Renal Function

참고문헌 (Reference)

1 Bedford RF, "The renal safety of sevofurane" 90 : 505-508, 2000

2 Katoh T, "The minimum alveolar concentration (MAC) of sevoflurane in humans" 66 : 301-303, 1987

3 Obata R, "The effects of prolonged low-flow sevoflurane anesthesia on renal and hepatic function" 91 : 1262-1268, 2000

4 Kobayashi Y, "Serum and urinary inorganic fluoride concentrations after prolonged inhalation of sevoflurane in humans" 74 : 753-757, 1992

5 Kharasch ED, "Role of renal cysteine conjugate beta-lyase in the mechanism of compound A nephrotoxicity in rats" 86 : 160-171, 1997

6 Bito H, "Renal and hepatic function in surgical patients after low-flow sevoflurane or isoflurane anesthesia" 82 : 173-176, 1996

7 Frink EJ Jr, "Plasma inorganic fluoride with sevoflurane anesthesia: correlation with indices of hepatic and renal function" 74 : 231-235, 1992

8 Eger EI II, "Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers" 84 : 160-168, 1997

9 Honemann CW, "Minimal- flow anaesthesia with controlled ventilation: comparison between laryngeal mask airway and endotracheal tube" 18 : 458-466, 2001

10 Goeters C, "Minimal flow sevoflurane and isoflurane anaesthesia and impact on renal function" 18 : 43-50, 2001

11 Chung CJ, "Minimal flow anaesthesia with continuous infusion of liquid enflurane or isoflurane into breathing circuit" 82 : 451-, 1999

12 Cousins MJ, "Methoxyflurane nephrotoxicity. A study of dose response in man" 225 : 1611-1616, 1973

13 Conzen PF, "Low-flow sevoflurane compared with low- flow isoflurane anesthesia in patients with stable renal insufficiency" 97 : 578-584, 2002

14 Odin I, "Low flow and economics of inhalational anaesthesia. Best Pract Res Clin" 19 : 399-413, 2005

15 .Kharasch ED, "Long-duration low-flow sevoflurane and isoflurane effects on postoperative renal and hepatic function" 93 : 1511-1520, 2001

16 Keller KA, "Inhalation toxicity study of a haloalkene degradant of sevoflurane, compound A (PIFE), in Sprague-Dawley rats" 83 : 1220-1232, 1995

17 Kharasch ED, "Human kidney methoxyflurane and sevoflurane metabolism: Intrarenal fluoride production as a possible mechanism of methoxyflurane nephrotoxicity" 82 : 689-699, 1995

18 Higuchi H, "Effects of sevoflurane and isoflurane on renal function and on possible markers of nephrotoxicity" 89 : 307-322, 1998

19 Bito H, "Effects of low-flow sevoflurane anesthesia on renal function: comparison with high-flow sevoflurane anesthesia and low-flow isoflurane anesthesia" 86 : 1231-1237, 1997

20 Bito H, "Degradation products of sevoflurane during low-flow anaesthesia" 74 : 56-59, 1995

21 Lee JK, "Comparison of enflurane consumptions and costs in low-flow and high-flow anesthesia" 37 : 574-579, 1999

22 Bito H, "Closed-circuit anesthesia with sevoflurane in humans: effects on renal and hepatic function and concentrations of breakdown products with soda lime in the circuit" 80 : 71-76, 1994

23 .Chung CJ, "Clinical evaluation of low- flow enflurane anesthesia in infants" 39 : 523-527, 2000

24 Kharasch ED, "Assessment of low-flow sevoflurane and isoflurane effects on renal function using sensitive markers of tubular toxicity" 86 : 1238-1253, 1997